Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1126964

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1126964

Asia Pacific RNA Analysis Market Size, Share & Industry Trends Analysis Report By Product, By Technology (Real Time-PCR Technology, Sequencing Technology, Microarray Technology), By End-use, By Application, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 134 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Asia Pacific RNA Analysis Market would witness market growth of 16.1% CAGR during the forecast period (2022-2028).

Increased attention to biomarker discovery and the high demand for transcriptomes in research and development activities have caused a spike in transcriptome production. According to the National Human Genome Research Institute, a division of the National Institutes of Health (NIH), two projects-the Mouse Transcriptome Project and the Mammalian Gene Collection Initiative-created transcriptome resources for researchers all over the world.

RNA underwent a revolution with the arrival of high-throughput next-generation sequencing (NGS) technologies. The advantages of Sanger sequencing and hybridization-based microarrays, which were previously employed to measure gene expression, were greatly reduced by this technical advancement. In a typical RNA-Seq experiment, RNA is isolated, transformed into complementary DNA (cDNA), the sequencing library is prepared, and the RNA is then sequenced on an NGS platform.

Before doing RNA-Seq, however, several experimental factors that rely on the goals of the researcher should be considered. The utilization of biological and technical replicates, the level of sequencing, and the desired coverage of the transcriptome are a few of these. These experimental alternatives may occasionally have a negligible effect on the accuracy of the data.

In 2019, China responded quickly to the coronavirus disease by utilizing digital healthcare technology. The establishment of the COVID-19 digital health ecosystem has been missed in existing research, despite the technical analysis and discussion of actual digital health innovations. The primary factors that led to China's rapid implementation of digital health initiatives by COVID-19, as well as to document and disseminate the lessons discovered. The most active and strategically important segment of the healthcare sales business for multinational corporations is medical equipment.

The China market dominated the Asia Pacific RNA Analysis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,903.3 million by 2028. The Japan market is estimated to grow a CAGR of 15.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 16.8% during (2022 - 2028).

Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Technology, the market is segmented into Real Time-PCR (qPCR) Technology, Sequencing Technology, Microarray Technology and Others. Based on End-use, the market is segmented into Government Institutes & Academic Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROs). Based on Application, the market is segmented into Infectious Diseases & Pathogenesis, Epigenetics, RNA Structure & Molecular Dynamics, Development & Delivery of RNA Therapeutics, Construction of RNA Expression Atlas, Alternative RNA Splicing and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, Merck Group, and Promega Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Kits & Reagents
  • Instruments
  • Services

By Technology

  • Real Time-PCR (qPCR) Technology
  • Sequencing Technology
  • Microarray Technology
  • Others

By End-use

  • Government Institutes & Academic Centers
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)

By Application

  • Infectious Diseases & Pathogenesis
  • Epigenetics
  • RNA Structure & Molecular Dynamics
  • Development & Delivery of RNA Therapeutics
  • Construction of RNA Expression Atlas
  • Alternative RNA Splicing
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific Group
  • Merck Group
  • Promega Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific RNA Analysis Market, by Product
    • 1.4.2 Asia Pacific RNA Analysis Market, by Technology
    • 1.4.3 Asia Pacific RNA Analysis Market, by End-use
    • 1.4.4 Asia Pacific RNA Analysis Market, by Application
    • 1.4.5 Asia Pacific RNA Analysis Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition & scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
    • 3.2.4 Geographical Expansions
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2022, Jun) Leading Players

Chapter 4. Asia Pacific RNA Analysis Market by Product

  • 4.1 Asia Pacific Kits & Reagents Market by Country
  • 4.2 Asia Pacific Instruments Market by Country
  • 4.3 Asia Pacific Services Market by Country

Chapter 5. Asia Pacific RNA Analysis Market by Technology

  • 5.1 Asia Pacific Real Time-PCR (qPCR) Technology Market by Country
  • 5.2 Asia Pacific Sequencing Technology Market by Country
  • 5.3 Asia Pacific Microarray Technology Market by Country
  • 5.4 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific RNA Analysis Market by End-use

  • 6.1 Asia Pacific Government Institutes & Academic Centers Market by Country
  • 6.2 Asia Pacific Hospitals & Clinics Market by Country
  • 6.3 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
  • 6.4 Asia Pacific Contract Research Organizations (CROs) Market by Country

Chapter 7. Asia Pacific RNA Analysis Market by Application

  • 7.1 Asia Pacific Infectious Diseases & Pathogenesis Market by Country
  • 7.2 Asia Pacific Epigenetics Market by Country
  • 7.3 Asia Pacific RNA Structure & Molecular Dynamics Market by Country
  • 7.4 Asia Pacific Development & Delivery of RNA Therapeutics Market by Country
  • 7.5 Asia Pacific Construction of RNA Expression Atlas Market by Country
  • 7.6 Asia Pacific Alternative RNA Splicing Market by Country
  • 7.7 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific RNA Analysis Market by Country

  • 8.1 China RNA Analysis Market
    • 8.1.1 China RNA Analysis Market by Product
    • 8.1.2 China RNA Analysis Market by Technology
    • 8.1.3 China RNA Analysis Market by End-use
    • 8.1.4 China RNA Analysis Market by Application
  • 8.2 Japan RNA Analysis Market
    • 8.2.1 Japan RNA Analysis Market by Product
    • 8.2.2 Japan RNA Analysis Market by Technology
    • 8.2.3 Japan RNA Analysis Market by End-use
    • 8.2.4 Japan RNA Analysis Market by Application
  • 8.3 India RNA Analysis Market
    • 8.3.1 India RNA Analysis Market by Product
    • 8.3.2 India RNA Analysis Market by Technology
    • 8.3.3 India RNA Analysis Market by End-use
    • 8.3.4 India RNA Analysis Market by Application
  • 8.4 South Korea RNA Analysis Market
    • 8.4.1 South Korea RNA Analysis Market by Product
    • 8.4.2 South Korea RNA Analysis Market by Technology
    • 8.4.3 South Korea RNA Analysis Market by End-use
    • 8.4.4 South Korea RNA Analysis Market by Application
  • 8.5 Singapore RNA Analysis Market
    • 8.5.1 Singapore RNA Analysis Market by Product
    • 8.5.2 Singapore RNA Analysis Market by Technology
    • 8.5.3 Singapore RNA Analysis Market by End-use
    • 8.5.4 Singapore RNA Analysis Market by Application
  • 8.6 Malaysia RNA Analysis Market
    • 8.6.1 Malaysia RNA Analysis Market by Product
    • 8.6.2 Malaysia RNA Analysis Market by Technology
    • 8.6.3 Malaysia RNA Analysis Market by End-use
    • 8.6.4 Malaysia RNA Analysis Market by Application
  • 8.7 Rest of Asia Pacific RNA Analysis Market
    • 8.7.1 Rest of Asia Pacific RNA Analysis Market by Product
    • 8.7.2 Rest of Asia Pacific RNA Analysis Market by Technology
    • 8.7.3 Rest of Asia Pacific RNA Analysis Market by End-use
    • 8.7.4 Rest of Asia Pacific RNA Analysis Market by Application

Chapter 9. Company Profiles

  • 9.1 F. Hoffmann-La Roche Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 Recent strategies and developments:
      • 9.1.5.1 Partnerships, Collaborations, and Agreements:
      • 9.1.5.2 Acquisition and Mergers:
  • 9.2 Danaher Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Acquisition and Mergers:
  • 9.3 Agilent Technologies, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Product Launches and Product Expansions:
      • 9.3.5.3 Acquisition and Mergers:
  • 9.4 Thermo Fisher Scientific, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Partnerships, Collaborations, and Agreements:
      • 9.4.5.2 Product Launches and Product Expansions:
      • 9.4.5.3 Acquisition and Mergers:
  • 9.5 Qiagen N.V.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
      • 9.5.5.2 Product Launches and Product Expansions:
  • 9.6 Illumina, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
      • 9.6.5.3 Acquisition and Mergers:
  • 9.7 Bio-Rad laboratories, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
  • 9.8 Eurofins Scientific Group
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Recent strategies and developments:
      • 9.8.4.1 Product Launches and Product Expansions:
  • 9.9 Merck Group
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Segmental and Regional Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Partnerships, Collaborations, and Agreements:
      • 9.9.5.2 Acquisition and Mergers:
  • 9.10. Promega Corporation
    • 9.10.1 Company Overview
    • 9.10.2 Recent strategies and developments:
      • 9.10.2.1 Product Launches and Product Expansions:
      • 9.10.2.2 Geographical Expansions:

LIST OF TABLES

  • TABLE 1 Asia Pacific RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 2 Asia Pacific RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- RNA Analysis Market
  • TABLE 4 Product Launches And Product Expansions- RNA Analysis Market
  • TABLE 5 Acquisition and Mergers- RNA Analysis Market
  • TABLE 6 Geographical Expansions - RNA Analysis Market
  • TABLE 7 Asia Pacific RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 8 Asia Pacific RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 9 Asia Pacific Kits & Reagents Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Asia Pacific Kits & Reagents Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Asia Pacific RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 16 Asia Pacific RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 17 Asia Pacific Real Time-PCR (qPCR) Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Asia Pacific Real Time-PCR (qPCR) Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Asia Pacific Sequencing Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Asia Pacific Sequencing Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Asia Pacific Microarray Technology Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Asia Pacific Microarray Technology Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 24 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 25 Asia Pacific RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 26 Asia Pacific RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 27 Asia Pacific Government Institutes & Academic Centers Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Asia Pacific Government Institutes & Academic Centers Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Asia Pacific Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Asia Pacific Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Asia Pacific RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 36 Asia Pacific RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 37 Asia Pacific Infectious Diseases & Pathogenesis Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Asia Pacific Infectious Diseases & Pathogenesis Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Asia Pacific Epigenetics Market by Country, 2018 - 2021, USD Million
  • TABLE 40 Asia Pacific Epigenetics Market by Country, 2022 - 2028, USD Million
  • TABLE 41 Asia Pacific RNA Structure & Molecular Dynamics Market by Country, 2018 - 2021, USD Million
  • TABLE 42 Asia Pacific RNA Structure & Molecular Dynamics Market by Country, 2022 - 2028, USD Million
  • TABLE 43 Asia Pacific Development & Delivery of RNA Therapeutics Market by Country, 2018 - 2021, USD Million
  • TABLE 44 Asia Pacific Development & Delivery of RNA Therapeutics Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Asia Pacific Construction of RNA Expression Atlas Market by Country, 2018 - 2021, USD Million
  • TABLE 46 Asia Pacific Construction of RNA Expression Atlas Market by Country, 2022 - 2028, USD Million
  • TABLE 47 Asia Pacific Alternative RNA Splicing Market by Country, 2018 - 2021, USD Million
  • TABLE 48 Asia Pacific Alternative RNA Splicing Market by Country, 2022 - 2028, USD Million
  • TABLE 49 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 50 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 51 Asia Pacific RNA Analysis Market by Country, 2018 - 2021, USD Million
  • TABLE 52 Asia Pacific RNA Analysis Market by Country, 2022 - 2028, USD Million
  • TABLE 53 China RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 54 China RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 55 China RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 56 China RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 57 China RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 58 China RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 59 China RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 60 China RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 61 China RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 62 China RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 63 Japan RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 64 Japan RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 65 Japan RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 66 Japan RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 67 Japan RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 68 Japan RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 69 Japan RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 70 Japan RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 71 Japan RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 72 Japan RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 73 India RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 74 India RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 75 India RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 76 India RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 77 India RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 78 India RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 79 India RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 80 India RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 81 India RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 82 India RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 83 South Korea RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 84 South Korea RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 85 South Korea RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 86 South Korea RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 87 South Korea RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 88 South Korea RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 89 South Korea RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 90 South Korea RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 91 South Korea RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 92 South Korea RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 93 Singapore RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 94 Singapore RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 95 Singapore RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 96 Singapore RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 97 Singapore RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 98 Singapore RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 99 Singapore RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 100 Singapore RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 101 Singapore RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 102 Singapore RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 103 Malaysia RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 104 Malaysia RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 105 Malaysia RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 106 Malaysia RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 107 Malaysia RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 108 Malaysia RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 109 Malaysia RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 110 Malaysia RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 111 Malaysia RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 112 Malaysia RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 113 Rest of Asia Pacific RNA Analysis Market, 2018 - 2021, USD Million
  • TABLE 114 Rest of Asia Pacific RNA Analysis Market, 2022 - 2028, USD Million
  • TABLE 115 Rest of Asia Pacific RNA Analysis Market by Product, 2018 - 2021, USD Million
  • TABLE 116 Rest of Asia Pacific RNA Analysis Market by Product, 2022 - 2028, USD Million
  • TABLE 117 Rest of Asia Pacific RNA Analysis Market by Technology, 2018 - 2021, USD Million
  • TABLE 118 Rest of Asia Pacific RNA Analysis Market by Technology, 2022 - 2028, USD Million
  • TABLE 119 Rest of Asia Pacific RNA Analysis Market by End-use, 2018 - 2021, USD Million
  • TABLE 120 Rest of Asia Pacific RNA Analysis Market by End-use, 2022 - 2028, USD Million
  • TABLE 121 Rest of Asia Pacific RNA Analysis Market by Application, 2018 - 2021, USD Million
  • TABLE 122 Rest of Asia Pacific RNA Analysis Market by Application, 2022 - 2028, USD Million
  • TABLE 123 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 124 Key Information - Danaher Corporation
  • TABLE 125 key Information - Agilent Technologies, Inc.
  • TABLE 126 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 127 Key Information - Qiagen N.V.
  • TABLE 128 key information - Illumina, Inc.
  • TABLE 129 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 130 Key Information - Eurofins Scientific Group
  • TABLE 131 key Information - Merck GrouP
  • TABLE 132 key Information - Promega Corporation

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun - 2022, Jun) Leading Players
  • FIG 5 Recent strategies and developments: F. Hoffmann-La Roche AG
  • FIG 6 Recent strategies and developments: Agilent Technologies, Inc.
  • FIG 7 Recent strategies and developments: Thermo Fisher Scientific, Inc.
  • FIG 8 Recent strategies and developments: Qiagen N.V.
  • FIG 9 Recent strategies and developments: Illumina, Inc.
  • FIG 10 Recent strategies and developments: Merck KGaA
  • FIG 11 Recent strategies and developments: Promega Corporation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!